Cargando…

Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment

Detalles Bibliográficos
Autores principales: Duijts, Liesbeth, Fleming, Louise J., Bacharier, Leonard B., Pitrez, Paulo M., Reddel, Helen K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838630/
https://www.ncbi.nlm.nih.gov/pubmed/35202561
http://dx.doi.org/10.1164/rccm.202112-2788LE
_version_ 1784869325209862144
author Duijts, Liesbeth
Fleming, Louise J.
Bacharier, Leonard B.
Pitrez, Paulo M.
Reddel, Helen K.
author_facet Duijts, Liesbeth
Fleming, Louise J.
Bacharier, Leonard B.
Pitrez, Paulo M.
Reddel, Helen K.
author_sort Duijts, Liesbeth
collection PubMed
description
format Online
Article
Text
id pubmed-9838630
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Thoracic Society
record_format MEDLINE/PubMed
spelling pubmed-98386302023-01-17 Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment Duijts, Liesbeth Fleming, Louise J. Bacharier, Leonard B. Pitrez, Paulo M. Reddel, Helen K. Am J Respir Crit Care Med Correspondence American Thoracic Society 2022-02-24 /pmc/articles/PMC9838630/ /pubmed/35202561 http://dx.doi.org/10.1164/rccm.202112-2788LE Text en Copyright © 2022 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . For commercial usage and reprints, please e-mail Diane Gern (dgern@thoracic.org).
spellingShingle Correspondence
Duijts, Liesbeth
Fleming, Louise J.
Bacharier, Leonard B.
Pitrez, Paulo M.
Reddel, Helen K.
Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment
title Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment
title_full Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment
title_fullStr Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment
title_full_unstemmed Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment
title_short Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment
title_sort reply to baraldi and piacentini: global initiative for asthma 2021: asthma in preschool children and short-acting β(2)-agonist–only treatment
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838630/
https://www.ncbi.nlm.nih.gov/pubmed/35202561
http://dx.doi.org/10.1164/rccm.202112-2788LE
work_keys_str_mv AT duijtsliesbeth replytobaraldiandpiacentiniglobalinitiativeforasthma2021asthmainpreschoolchildrenandshortactingb2agonistonlytreatment
AT fleminglouisej replytobaraldiandpiacentiniglobalinitiativeforasthma2021asthmainpreschoolchildrenandshortactingb2agonistonlytreatment
AT bacharierleonardb replytobaraldiandpiacentiniglobalinitiativeforasthma2021asthmainpreschoolchildrenandshortactingb2agonistonlytreatment
AT pitrezpaulom replytobaraldiandpiacentiniglobalinitiativeforasthma2021asthmainpreschoolchildrenandshortactingb2agonistonlytreatment
AT reddelhelenk replytobaraldiandpiacentiniglobalinitiativeforasthma2021asthmainpreschoolchildrenandshortactingb2agonistonlytreatment